Agilon, Baby Boy .
HRN: 24-76-94 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/08/2024
AMPICILLIN 500MG (VIAL)
04/08/2024
04/15/2024
IV
150mg
Q12hrs
Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes